Yichen Cao
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Molecular Biology Techniques and Applications 2
-
- Prostate Cancer Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 3
- Co-authors
- Christopher Carter (1 shared paper)Dean Wilkie (1 shared paper)Xiaomei Zhang (1 shared paper)Li Liu (1 shared paper)Charles Chen (1 shared paper)Scott M. Wilhelm (1 shared paper)Mark Lynch (1 shared paper)Ralph Buttyan (5 shared papers)
- Journals
- The Journal of Urology (4 papers)Cancer Research (3 papers)Urology (1 paper)Molecular Therapy (1 paper)Cornea (1 paper)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Yichen Cao
15 papers receiving 1.6k citations
Yichen Cao's Hit Papers
Peers
Comparison fields: 5 of 97
- Hepatology 432
- Cancer Research 352
- Pathology and Forensic Medicine 333
- Oncology 393
- Molecular Biology 817
Countries citing papers authored by Yichen Cao
This map shows the geographic impact of Yichen Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichen Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichen Cao more than expected).
Fields of papers citing papers by Yichen Cao
This network shows the impact of papers produced by Yichen Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichen Cao. The network helps show where Yichen Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yichen Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5 Hit paper breakdown → | 2006 | 1273 |
| 2 | 1999 | 144 | |
| 3 | 1996 | 84 | |
| 4 | 1999 | 44 | |
| 5 | 2017 | 34 | |
| 6 | 2017 | 31 | |
| 7 | 2022 | 18 | |
| 8 | 2000 | 17 | |
| 9 | 1999 | 13 | |
| 10 | 2011 | 8 | |
| 11 | 2019 | 6 | |
| 12 | 2012 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 1996 | 2 | |
| 15 | 2013 | 1 | |
| 16 | 2022 | 0 |
About Yichen Cao
Yichen Cao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery and Neurology, having authored 16 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers), Neuroblastoma Research and Treatments (2 papers), Molecular Biology Techniques and Applications (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Hepatology (432 citations), Cancer Research (352 citations), Pathology and Forensic Medicine (333 citations), Oncology (393 citations) and Molecular Biology (817 citations). Yichen Cao has collaborated with scholars based in United States, China and France. Frequent co-authors include Christopher Carter, Dean Wilkie, Xiaomei Zhang, Li Liu, Charles Chen, Scott M. Wilhelm, Mark Lynch, Ralph Buttyan, Alexandre de la Taille and Martin Burchardt. Their work appears in journals such as The Journal of Urology, Cancer Research, Urology, Molecular Therapy and Cornea.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.